Scor SE [SCR] vs Axa S.A [CS] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: Scor SE wins in 12 metrics, Axa S.A. wins in 6 metrics, with 0 ties. Scor SE appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Scor SE | Axa S.A. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 6.91 | 12.12 | Scor SE |
| Price-to-Book Ratio | 1.31 | 1.81 | Scor SE |
| Debt-to-Equity Ratio | 55.37 | 113.52 | Scor SE |
| PEG Ratio | 0.00 | N/A | N/A |
| EV/EBITDA | 5.70 | 7.06 | Scor SE |
| Profit Margin (TTM) | 5.42% | 10.35% | Axa S.A. |
| Operating Margin (TTM) | 5.36% | 10.54% | Axa S.A. |
| EBITDA Margin (TTM) | 5.36% | 10.54% | Axa S.A. |
| Return on Equity | 12.94% | 13.42% | Axa S.A. |
| Return on Assets (TTM) | 2.24% | 1.01% | Scor SE |
| Free Cash Flow (TTM) | $1.13B | $21.92B | Axa S.A. |
| Dividend Yield | 6.36% | 5.15% | Scor SE |
| 1-Year Return | 1.85% | -4.29% | Scor SE |
| Price-to-Sales Ratio (TTM) | 0.37 | 0.90 | Scor SE |
| Enterprise Value | $7.91B | $84.46B | Axa S.A. |
| EV/Revenue Ratio | 0.50 | 0.89 | Scor SE |
| Revenue per Share (TTM) | $88 | $45 | Scor SE |
| Earnings per Share (Diluted) | $4.68 | $3.42 | Scor SE |
| Beta (Stock Volatility) | 0.51 | 0.61 | Scor SE |
Scor SE vs Axa S.A. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Scor SE | -0.66% | -4.77% | 2.50% | -0.39% | -0.39% | -0.39% |
| Axa S.A. | -1.89% | -1.61% | -0.72% | -1.85% | 3.08% | -2.86% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Scor SE | 1.85% | 1.85% | 1.85% | 1.85% | 1.85% | 1.85% |
| Axa S.A. | -4.29% | 45.80% | 74.03% | 82.67% | 170.09% | 59.17% |
Performance & Financial Health Analysis: Scor SE vs Axa S.A.
| Metric | SCR | CS |
|---|---|---|
| Market Information | ||
| Market Cap | €5.80B | €84.87B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 462,788 | 3,945,744 |
| 90 Day Avg. Volume | 684,240 | 4,870,216 |
| Last Close | €30.14 | €39.03 |
| 52 Week Range | €25.30 - €33.48 | €36.55 - €43.61 |
| % from 52W High | -9.98% | -10.50% |
| All-Time High | €43.79 (Nov 05, 2018) | €43.61 (Aug 15, 2025) |
| % from All-Time High | -31.17% | -10.50% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.07% | 0.03% |
| Quarterly Earnings Growth | -0.10% | 0.52% |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | 0.10% |
| Operating Margin (TTM) | 0.05% | 0.11% |
| Return on Equity (TTM) | 0.13% | 0.13% |
| Debt to Equity (MRQ) | 55.37 | 113.52 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €24.72 | €22.95 |
| Cash per Share (MRQ) | €19.93 | €33.60 |
| Operating Cash Flow (TTM) | €1.17B | €22.67B |
| Levered Free Cash Flow (TTM) | €1.07B | €10.82B |
| Dividends | ||
| Last 12-Month Dividend Yield | 6.36% | 5.15% |
| Last 12-Month Dividend | €1.80 | €2.15 |
Valuation & Enterprise Metrics Analysis: Scor SE vs Axa S.A.
| Metric | SCR (Apr 24, 2026) | CS (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 6.91 | 12.12 |
| Forward P/E | 7.18 | 9.33 |
| PEG Ratio | 0.00 | N/A |
| Price to Sales (TTM) | 0.37 | 0.90 |
| Price to Book (MRQ) | 1.31 | 1.81 |
| Market Capitalization | ||
| Market Capitalization | €5.80B | €84.87B |
| Enterprise Value | €7.91B | €84.46B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.50 | 0.89 |
| Enterprise to EBITDA | 5.70 | 7.06 |
| Risk & Other Metrics | ||
| Beta | 0.51 | 0.61 |
| Book Value per Share (MRQ) | €24.72 | €22.95 |
Financial Statements Comparison: Scor SE vs Axa S.A.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | SCR (2025) | CS (2025) |
|---|---|---|
| Revenue/Sales | 14.80B | 105.93B |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | 0.0% | 0.0% |
| Gross Profit | N/A | N/A |
| Gross Margin | 0.0% | 0.0% |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | N/A |
| Operating Margin | 0.0% | 0.0% |
| EBITDA | N/A | N/A |
| EBITDA Margin | 0.0% | 0.0% |
| Pre-Tax Income | 1.18B | 10.00B |
| Pre-Tax Income % of Revenue | 8.0% | 9.4% |
| Income Tax | 332.00M | 2.37B |
| Income Tax % of Revenue | 2.2% | 2.2% |
| Net Income (Profit) | 851.00M | 9.98B |
| Profit Margin | 5.8% | 9.4% |
Balance Sheet & Liquidity Metrics
| Metric | SCR (2025) | CS (2025) |
|---|---|---|
| Cash & Equivalents | 1.84B | 22.25B |
| Total Current Assets | N/A | N/A |
| Total Current Assets % of Revenue | 0.0% | 0.0% |
| Total Current Liabilities | N/A | N/A |
| Total Current Liabilities % of Revenue | 0.0% | 0.0% |
| Long-Term Debt | 3.52B | 60.49B |
| Long-Term Debt % of Revenue | 23.8% | 57.1% |
| Total Shareholders Equity | 4.43B | 49.56B |
| Retained Earnings | 851.00M | 41.41B |
| Retained Earnings % of Revenue | 5.8% | 39.1% |
| Property, Plant & Equipment | 838.00M | N/A |
Cash Flow Statement Comparison
| Metric | SCR (2025) | CS (2025) |
|---|---|---|
| Operating Cash Flow | 752.00M | 16.35B |
| Operating Cash Flow % of Revenue | 5.1% | 15.4% |
| Capital Expenditures | -24.00M | -425.00M |
| Free Cash Flow | 1.13B | 21.92B |
| FCF Margin | 7.6% | 20.7% |
| Debt Repayment | -414.00M | 0 |
| Common Stock Repurchase | -50.00M | -7.32B |
Short Interest & Institutional Ownership Analysis
| Metric | SCR | CS |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 179.07M | 2.06B |
| Float Shares | 169.99M | 1.54B |
| % Held by Insiders | 3.33% | 20.61% |
| % Held by Institutions | 51.81% | 38.25% |
| % Held by Public | 44.86% | 41.14% |
Dividend Analysis & Yield Comparison: Scor SE vs Axa S.A.
| Metric | SCR | CS |
|---|---|---|
| Last 12-Month Dividend | €1.80 | €2.15 |
| Last 12-Month Dividend Yield | 6.36% | 5.15% |
| 3-Year Avg Annual Dividend | €1.67 | €1.94 |
| 3-Year Avg Dividend Yield | 6.27% | 5.92% |
| 3-Year Total Dividends | €5.00 | €5.83 |
| Ex-Dividend Date | May 02, 2025 | May 05, 2025 |